Evaluation of IGM-7354 in Adults With Relapsed and/or Refractory Cancer

NCT05702424 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: IGM-7354

Sponsor

IGM Biosciences, Inc.